Bevacizumab (Avastin®)
Bevacizumab (Avastin®) is a pharmaceutical drug with 84 clinical trials. Currently 3 active trials ongoing. Historical success rate of 87.0%.
Success Metrics
Based on 60 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
45
Mid Stage
20
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.9%
60 of 77 finished
22.1%
17 ended early
3
trials recruiting
84
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Bevacizumab In Hereditary Hemorrhagic Telangiectasia
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization
Clinical Trials (84)
Bevacizumab In Hereditary Hemorrhagic Telangiectasia
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization
The Avastin vs Visudyne for Neovascular AMD Study
Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Escalated Dose of Irinotecan in mCRC
The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors
Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.
Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 84